Bi-allelic variants in IPO۸ cause human importin- β -related disorders

سال انتشار: 1400
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 115

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

CHGGE01_133

تاریخ نمایه سازی: 13 مهر 1401

چکیده مقاله:

Backgrounds: IPO۸ protein encodes Importin ۸ which translocates cargo molecules into thenucleus. One of them is TGF-β signaling components, dysregulated transforming growth factors,which cause connective tissue disorders. Bi-allelic loss-of-function variants in IPO۸ cause asyndromic form of thoracic aortic aneurysm (TAA) with clinical overlap with Loeys-Dietz andShprintzen-Goldberg syndromes. Here, we reported two patients (male and female) fromunrelated families with variants in IPO۸ with symptoms like cardio-vascular anomalies,connective tissue findings, craniofacial dysmorphic features, developmental delay, and immunedysregulation.Materials and Methods: We performed whole-exome sequencing and Sanger sequencing toidentify pathogenic variant(s) in the families. By using CRISPR/ Cas۹-mediated inactivation inzebrafish, the role of IPO۸ in nuclear translocation was identified. A mild to the severe defectingpattern in the early embryonic development level of zebrafish based on the IPO۸’S role in TGF-βsignaling was demonstrated as well as severe cardiovascular and skeletal defects. In addition, byusing the C۵۷BL/۶N IPO۸ knockout mouse model cardiovascular defects in both sexes areshown.Results: A homozygous variant, IPO۸: c.۷۲۸del (p.Pro۲۴۳LeufsTer۲۷) in the male proband andIPO۸: c.۲۳۴۷_۲۳۶۹del (p.Leu۷۸۳ValfsTer۵) in female patient is identified. It is demonstratedthat IPO۸ deficiency leads to TGF-β signalopathy which has functions in the development,patterning, and homeostasis of the affected tissues.Conclusion: Our work demonstrated that IPO۸ has an important role in TGF-β signaling andcauses connective tissue defect. we know importin ۸ is a TGF-β-related effector and involve inTAA pathogenesis so far, next future opportunities would be mechanistic studies andrepresenting candidate drug targets for TAA.

نویسندگان

Paria Najarzadeh Torbati

Department of Medical Genetics, Next Generation Genetic Polyclinic, Mashhad, Iran

Mohammad Doosti

Department of Medical Genetics, Next Generation Genetic Polyclinic, Mashhad, Iran

Najmeh Ahangari

Department of Medical Genetics, Next Generation Genetic Polyclinic, Mashhad, Iran

Mehran Beiraghi Toosi

Department of Pediatric Neurology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

Mojaba Safi

Department of Medical Genetics, Next Generation Genetic Polyclinic, Mashhad, Iran

Hassan Mottaghi Moghaddam Shahri

Pediatric Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran